【摘要】：正(www.truking.cn)楚天科技股份有限公司董事長(zhǎng)兼總裁唐岳認(rèn)為,中國(guó)醫(yī)藥產(chǎn)業(yè)應(yīng)將80%精力放在機(jī)器人集成應(yīng)用上,而非機(jī)器人研究。機(jī)器人概念在中國(guó)非常流行,但對(duì)于醫(yī)藥產(chǎn)業(yè)來(lái)說(shuō),應(yīng)將80%的精力放在應(yīng)用上,而非研究。全球機(jī)器人研究已經(jīng)到了一定階段,故沒(méi)必要從零起步去研究,如何把既有成果成功集成到我們的系統(tǒng)里,如何讓既有成果適應(yīng)醫(yī)藥產(chǎn)
[Abstract]:Tang Yue, chairman and president of www.truking.cn Chutian Technology Co., said the Chinese pharmaceutical industry should focus on robotic integration applications, not robotics research. The concept of robots is very popular in China, but for the pharmaceutical industry, 80% of the focus should be on applications rather than research. Global robot research has reached a certain stage, so there is no need to start from scratch, how to successfully integrate the existing results into our system, how to adapt the existing results to the pharmaceutical industry
【作者單位】： 楚天科技股份有限公司;
【分類(lèi)號(hào)】：F426.72;TP242
，

本文編號(hào)：2293111